INSIGHTS ON DRUG DEVELOPMENT

• Accelerating Clinical Development: Modern Tools In Process Chemistry

  Whether you aim to address bottlenecks or explore advanced techniques, gain a practical and forward-thinking perspective to streamline early-phase development with HTE and model-based approaches.

• Breaking The Chains Of Conventional Drug Research Models

  Gain insight into the limitations of conventional research models, how Organ-Chips are helping researchers bridge the translation gap and overcome pervasive barriers in drug development, and more.

• A CDMO Is The Nexus Between Green Chemistry And Commercialization

  Modern R&D transforms sustainability from an optional add-on into a strategic optimization tool, enhancing cost-efficiency, speed to market, and process intensification for drug developers.

• Improving The Efficiency And Quality Of Advanced Imaging And Analysis

  Human-relevant models are transforming drug screening. Find out how overcoming 3D cell culture challenges with integrated innovations accelerates discovery and brings effective treatments to patients faster.

• Thunderstruck By Antibody-Drug Conjugates

  3/18/2025

  Antibody-drug conjugates are transforming cancer treatment by targeting tumors directly to reduce side effects. Discover how they affect neighboring cells, which can enhance treatment efficacy and eliminate tumor cell populations.

• Multifactorial Disease Models: De-Risking Topical Formulation Development

  10/20/2025

  Traditional drug models fail to predict performance in human skin. Advanced, multifactorial ex vivo disease models directly address inflammation and infection to de-risk formulation development.

• Exploring Neuroinflammation, Neurodegeneration With A Brain Organ-Chip

  4/9/2024

  Examine how Organ-on-a-Chip technology, accurately mimicking human neuroinflammation, offers promising human-relevant avenues for neurodegenerative disease research and therapeutic development.

• How To Reduce Batch Loss In Biopharma Production

  12/12/2025

  Batch failures in biopharma remain costly despite improvements. Learn the leading causes in downstream purification and how supplier expertise can help reduce risk and protect production.

• Evaluating Compound Toxicity Effects On Healthy Intestinal Organoids

  3/24/2025

  3D organoids enhance drug toxicity prediction and are crucial for anti-cancer drug development. Examine a method using 3D mouse intestinal organoids that aims to provide vital data on intestinal toxicity.